LOX is an HIF-1 target gene, and the tumor-secreted LOX in xenograft models is an important modulator of bone homeostasis, with increased osteoclast number, highlighting the potential of therapeutic strategies devised to hamper the formation of pre-metastatic lesions driven by osteoclasts and mediated by LOX in the bone [41]. The gene discussed is LOX; the disease is neoplasm.